Elsevier Announces Genomic and Personalized Medicine Conference Supported by The Lancet
Oxford, UK, 13 January 2010 - Elsevier announced today the Genomic and Personalized Medicine Conference in Arlington, VA, USA from May 16-18, 2010, which is, supported by The Lancet and organized in association with the book ‘Genomic and Personalized Medicine’ by Huntington Willard and Geoffrey Ginsburg.
The conference will serve the needs of a wide group of stakeholders - practicing physicians, physician-scientists, industry leaders, policy makers, and other health care professionals and trainees at all levels. The conference will embrace one of the most promising avenues for advances in diagnosis, prevention, and treatment of human disease.
The topics that will be covered have been derived from the comprehensive, two-volume book ‘Genomic and Personalized Medicine’ published in 2009 and will provide in-depth coverage of the field of genomic and personalized medicine, including genomic and other technologies, state-of-the art of genetic and genomic discoveries for individual diseases and practical uses of genome-based information in clinical medicine. Delegates to this event will be offered a 25% reduction on the two-volume book.
Christine Minihane, Senior Acquisitions Editor for the book commented “Elsevier is proud to be the publisher of ‘Genomic and Personalized Medicine’ and the sponsor of this conference. The work of Huntington Willard and Geoff Ginsburg and their colleagues should be commended. They are defining a field which has valuable implications for all areas of health care research and practice. Elsevier is pleased to have the opportunity to support the collaboration which will transform the practice of diagnosis, prevention and treatment of human disease.”
‘Genomic and Personalized Medicine’ is now inviting abstract submissions from the wider audience for poster presentation; however a select number of abstracts may be chosen for oral presentation at the conference. Abstracts should be submitted by February 8, 2010.
More information about this event can be found at www.genomicandpersonalizedmedicine.com.About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+44 1865 843181